Newsletter | May 19, 2025

05.19.25 -- Therapy Delivery Options For Autoimmune And Allergic Diseases

SPONSOR

The PDA Miniverse: Medical Devices, Combination Products and Connected Health Conference 2025 is coming to Indianapolis, IN on 25-26 June 2025. We have curated top thought leadership presentations, a group of impressive solution providers, and a highly networked experience designed to maximize your time and investment. As a community with a shared purpose, we will address industry trends that are shaping the health tech landscape.

FEATURED EDITORIAL

Therapy Delivery Options For Autoimmune And Allergic Diseases

By Drug Delivery Leader: In Combination

This videocast and transcript combines the perspectives of three executives at Revolo Biotherapeutics in a discussion about developing and delivering peptide-based alternatives to steroids for allergic and autoimmune diseases.

Smart Drug Delivery Systems: Emerging Market Trends

By Pooja Sharma, Global Market Insights

According to new market research, the global smart drug delivery systems market reached $12 billion in 2024 and is expected to grow at a CAGR of 17% from 2025 to 2034. Check out this article for product trends and more.

INDUSTRY INSIGHTS

Strategies For Success With Highly Potent Oral Solids

Q&A | Catalent

Here, industry experts discuss key challenges in HPAPI drug product manufacturing and highlight essential factors sponsors should consider when evaluating a CDMO partner.

In-Home Administration: Implications For Patients, Providers, And Design

Article | By Grace Lillie, Battelle

Healthcare is shifting homeward. With telehealth, connected devices, and user-friendly design, patients and caregivers now deliver hospital-level care safely and effectively outside clinical settings.

Enhancing Drug Delivery Project Speed And Success

Webinar | SMC Ltd.

Hear from experienced professionals in the drug delivery space on how to ensure success and speed-to-market by establishing a firm foundation when working with a CMO.

Patient-Centric Solutions To Optimize Medication Adherence

e-book | Catalent

Uncover how orally disintegrating tablets act as a patient-centric solution to various factors that impact treatment adherence rates across various diseases.

Formulation Challenges And Advances In Ophthalmic Drug Delivery

Article | By Dr. Tamas Solymosi, Nanoform

Review the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs

White Paper | Stevanato Group

Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.

SOLUTIONS

Easy-To-Use 1 mL Disposable Autoinjector

BD Medical - Pharmaceutical Systems